表紙
市場調査レポート

持続性アレルギー性鼻炎:世界の治験レビュー

Persistent Allergic Rhinitis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322164
出版日 ページ情報 英文 61 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.16円で換算しております。
Back to Top
持続性アレルギー性鼻炎:世界の治験レビュー Persistent Allergic Rhinitis Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 61 Pages
概要

当レポートでは、持続性アレルギー性鼻炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 持続性アレルギー性鼻炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:呼吸器系疾患の治験における持続性アレルギー性鼻炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患の治験における持続性アレルギー性鼻炎の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

持続性アレルギー性鼻炎治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Nuvo Research Inc.
    • J Uriach Y Compania, S.A.
    • Eurofarma Laboratorios S.A.
    • Theon Pharmaceuticals Ltd.
    • 武田薬品工業
    • Nuvo Research GmbH
    • EMS S.A.
    • Dong Wha Pharma Co., Ltd.
    • DCC Healthcare Limited
  • 代表的な研究機関・病院の治験の概要
    • Department of Health, South Africa
    • National Research Council of Thailand
    • Istituto Giannina Gaslini
    • The University of Sydney

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2506CTIDB

GlobalData's clinical trial report, "Persistant Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Persistant Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Persistant Allergic Rhinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Persistant Allergic Rhinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Persistant Allergic Rhinitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Persistant Allergic Rhinitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Persistant Allergic Rhinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Nuvo Research Inc.
      • Clinical Trial Overview of Nuvo Research Inc.
      • J Uriach Y Compania, S.A.
      • Clinical Trial Overview of J Uriach Y Compania, S.A.
      • Eurofarma Laboratorios S.A.
      • Clinical Trial Overview of Eurofarma Laboratorios S.A.
      • Theon Pharmaceuticals Ltd.
      • Clinical Trial Overview of Theon Pharmaceuticals Ltd.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Nuvo Research GmbH
      • Clinical Trial Overview of Nuvo Research GmbH
      • EMS S.A.
      • Clinical Trial Overview of EMS S.A.
      • Dong Wha Pharma Co., Ltd.
      • Clinical Trial Overview of Dong Wha Pharma Co., Ltd.
      • DCC Healthcare Limited
      • Clinical Trial Overview of DCC Healthcare Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • National Research Council of Thailand
      • Clinical Trial Overview of National Research Council of Thailand
      • Istituto Giannina Gaslini
      • Clinical Trial Overview of Istituto Giannina Gaslini
      • The University of Sydney
      • Clinical Trial Overview of The University of Sydney
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research Inc., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by J Uriach Y Compania, S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma Laboratorios S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theon Pharmaceuticals Ltd., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuvo Research GmbH, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by EMS S.A., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Wha Pharma Co., Ltd., 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DCC Healthcare Limited, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Research Council of Thailand, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2014*

List of Figures

  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Persistant Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Persistant Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Persistant Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top